Marihuana for Medical Purposes Regulations

The Marihuana for Medical Purposes Regulations (MMPR) is a set of Canadian regulations enacted in July 2013 concerning the production, distribution and use of medical marijuana.[1] (Note: in Canada the spelling "marihuana" is used instead of the United States' spelling of marijuana.) Portions of the law become effective on October 1, 2013, March 31, 2014 and March 31, 2015.

The MMPR program replaces the Marihuana Medical Access Regulations (MMAR). The MMAR was enacted in July 2001.[2] Prior to a federal injunction, the MMAR program was to end on March 31, 2014. The MMAR program was intended to clearly define the circumstances and the manner in which access to marihuana for medical purposes would be permitted. It contained three main components: authorizations to possess dried marihuana; licences to produce marihuana, which include Personal-Use Production Licences and Designated-Person Production Licences; and access to supply of marihuana seeds or dried marihuana.[3]

The MMPR was introduced in response to concerns from stakeholders that the MMAR was open to abuse. The MMPR treats marihuana as much as possible like any other narcotic used for medical purposes by creating conditions for a new, commercial industry that is responsible for its production and distribution. According to Health Canada, the regulations "will provide access to quality-controlled marihuana for medical purposes, produced under secure and sanitary conditions, to those Canadians who need it, while strengthening the safety of Canadian communities. In addition, the new regulations will also enable more choices of marihuana strains and licensed, commercial suppliers."[3]

Under the MMPR, Health Canada maintains a list of authorized licensed producers of medical marihuana.[4]

The transition from the MMAR to the MMPR program represents a substantial change in direction for the supply and acquisition of medical marihuana in Canada. It has not gone without controversy. The MMAR DPL/PPL Coalition Against Repeal is a coalition of over 6,000 members fighting for the preservation of the MMAR. An exemption was granted by a Federal Court Judge in British Columbia and permits clients who had a valid authorization to possess and/or a production license as of March 21, 2014 to continue to grow until the outcome of a Constitutional Challenge Trial that started in February 2015. [5] [6]

References

  1. ↑ "Marihuana for Medical Purposes Regulations". Justice Laws Website. Government of Canada. Retrieved 2014-03-02.
  2. ↑ "Marihuana Medical Access Regulations". Justice Laws Website. Government of Canada. Retrieved 2014-03-02.
  3. 1 2 "Frequently Asked Questions: Medical Use of Marihuana". Health Canada. Retrieved 2014-03-02.
  4. ↑ "List of Authorised Licensed Producers under the Marihuana for Medical Purposes Regulations". Health Canada. 2014-02-27. Retrieved 2014-03-03.
  5. ↑ "The MMAR DPL/PPL Coalition Against Repeal". MMAR Coalition Against Repeal. 2014-06-17. Retrieved 2014-03-03.
  6. ↑ http://www.johnconroy.com/mmar.htm
This article is issued from Wikipedia - version of the Friday, February 19, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.